Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000198034 | SCV000249931 | likely benign | not provided | 2019-05-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002228863 | SCV000549007 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000680503 | SCV000807887 | likely benign | Connective tissue disorder | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004020355 | SCV005032226 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2023-01-26 | criteria provided, single submitter | clinical testing | The p.S428L variant (also known as c.1283C>T), located in coding exon 8 of the COL5A1 gene, results from a C to T substitution at nucleotide position 1283. The serine at codon 428 is replaced by leucine, an amino acid with dissimilar properties. This alteration has been reported in a whole exome sequencing cohort (Stranneheim H et al. Genome Med, 2021 Mar;13:40). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |